Risk Stratification, Early Prevention and Treatment Strategies for Arrhythmogenic Cardiomyopathy

Recruiting now

Conditions studied: Arrhythmogenic Cardiomyopathy

In brief

This study will include patients diagnosed with Arrhythmogenic cardiomyopathy (ACM) in the First Affiliated Hospital of Xi 'an Jiaotong University and other centers, and collect clinical data and biological samples of patients with different ACM phenotypes. Through the establishment of disease cohort and long-term follow-up, to explore the disease characteristics, development law, clinical characteristics, natural course of disease and long-term prognosis of ACM.

Key facts

Study ID

NCT06352307

Run by

First Affiliated Hospital Xi'an Jiaotong University

People needed

1500

Starts

2024-04-09

Expected to finish

2032-08-31

Last updated by the study team

2024-07-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age >18 years old.
• The diagnosis of ACM was confirmed by cardiac ultrasound, electrocardiogram, magnetic resonance angiography, pathological examination and gene sequencing.
• Patients or their families agreed to participate in the study and authorized informed consent.

You may not qualify if…

• Incomplete clinical data.
• Do not agree to the inclusion or refuse to authorize the informed consent.

Where it is running

• First Affiliated Hospital of Xi'an Jiantong University — Xi'an, Shaanxi, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.